The Investor Relations website contains information about Evoke Pharma, Inc.'s business for stockholders, potential investors, and financial analysts.
SOLANA BEACH, Calif. , March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused ...
Investor Relations. Overview · Press Releases · SEC ... Evoke Pharma 4th Quarter and Full Year 2023 Earnings Webcast ... Evoke Pharma to Present at Rodman & Renshaw ...
Missing: evok | Show results with:evok
People also ask
What does Evoke Pharma do?
Where is Evoke Pharma located?
Jul 26, 2021 · WHO WE ARE At Evoke Pharma, Inc. (NASDAQ: EVOK) ... Investor Relations. Overview · Press Releases ... WHO WE ARE. At Evoke Pharma, Inc. (NASDAQ: EVOK) ...
Find annual and quearterly earnings data for Evoke Pharma, Inc. Common Stock (EVOK) including earnings per share, earnings forecasts at Nasdaq.com.
Dear Stockholder: The annual meeting of stockholders of Evoke Pharma, Inc. will be held at our offices located at 420 Stevens Avenue, Suite 370, Solana Beach, ...
Evoke Pharma, Inc. (EVOK) Q4 2023 Earnings Call Transcript
seekingalpha.com › article › 4678378-ev...
Mar 14, 2024 · (NASDAQ:EVOK) Q4 2023 Results Conference Call March 14, 2024 4:30 PM ET. Company Participants. Daniel Kontoh-Boateng - Investor Relations
Our mission is to identify, invest, and help build businesses that are seeking solutions to some of the hardest challenges in the climate technology sector.
Missing: investor | Show results with:investor
Evoke Pharma, Inc. (NASDAQ: EVOK) is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI) diseases.